Evaluating iron status and the risk of anemia in young infants using erythrocyte parameters

Ingrid Kristin Torsvik1, Trond Markestad, Per Magne Ueland

  • 1Department of Pediatrics, Haukeland University Hospital, Bergen, Norway. idto@helse-bergen.no

Pediatric Research
|November 22, 2012
PubMed

Insights

Iron supplementation improved iron status in infants, with reticulocyte hemoglobin content (CHr) effectively monitoring iron levels. Early CHr measurements can predict future anemia in at-risk infants.

Area of Science:

  • Pediatric Nutrition
  • Hematology
  • Infant Development

Background:

  • Accurate iron status assessment is crucial in young infants due to potential negative impacts of both deficiency and excess on development and health.
  • Iron deficiency and overload can adversely affect infant growth, development, and morbidity.

Purpose of the Study:

  • To evaluate iron status in infants using erythrocyte parameters, including reticulocyte hemoglobin content (CHr).
  • To assess the effectiveness of iron supplementation in infants with low birth weight.
  • To identify predictors of anemia in infants.

Main Methods:

  • Erythrocyte parameters, including reticulocyte hemoglobin content (CHr), were used to evaluate iron status in infants with birth weight <3,000 g.
  • Infant characteristics and blood samples were collected at 6 weeks, 4 months, and 6 months.
  • Iron supplementation was recommended for infants with a birth weight ≤2,500 g.

Main Results:

  • Iron-supplemented infants showed significantly higher hemoglobin (Hb) and CHr levels at 6 months compared to non-supplemented infants.
  • Prolonged exclusive breastfeeding, high weight gain, and male gender were identified as factors predisposing to low iron status at 6 months.
  • A CHr cutoff level of 26.9 pg at 4 months predicted anemia at 6 months with high sensitivity.

Conclusions:

  • Nonsupplemented infants with birth weights between 2,501-3,000 g exhibited signs of iron-restricted erythropoiesis.
  • Reticulocyte hemoglobin content (CHr) proved to be a valuable tool for assessing iron status in infants.
  • Further evaluation is needed regarding the necessity of iron supplementation in specific infant risk populations.
Abstract

Related Concept Videos

Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...